Search

everythinglearnresearchcommunity

for

Search:↓

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Gene variation affects prostate issues and hair loss.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Certain drugs that block specific enzymes can help treat prostate diseases.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Diabetes may lower the risk of prostate cancer.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.